Your browser doesn't support javascript.
loading
Genomic Signatures from Clinical Tumor Sequencing in Patients with Breast Cancer Having Germline BRCA1/2 Mutation.
Kim, Ju Won; Kang, Hyo Eun; Choi, Jimi; Yun, Seung Gyu; Jung, Seung Pil; Bae, Soo Yeon; You, Ji Young; Choi, Yoon-Ji; Kim, Yeul Hong; Park, Kyong Hwa.
Afiliação
  • Kim JW; Division of Medical Oncology and Hematology, Department of Internal Medicine, Korea University Anam Hospital, Seoul, Korea.
  • Kang HE; K-MASTER Cancer Precision Medicine Diagnosis and Treatment Enterprise, Korea University Medical Center, Seoul, Korea.
  • Choi J; Division of Endocrinology, Department of Internal Medicine, Korea University Anam Hospital, Seoul, Korea.
  • Yun SG; Department of Laboratory Medicine, Korea University Anam Hospital, Seoul, Korea.
  • Jung SP; Department of Breast Surgery, Korea University Anam Hospital, Seoul, Korea.
  • Bae SY; Department of Breast Surgery, Korea University Anam Hospital, Seoul, Korea.
  • You JY; Department of Breast Surgery, Korea University Anam Hospital, Seoul, Korea.
  • Choi YJ; Division of Medical Oncology and Hematology, Department of Internal Medicine, Korea University Anam Hospital, Seoul, Korea.
  • Kim YH; Division of Medical Oncology and Hematology, Department of Internal Medicine, Korea University Anam Hospital, Seoul, Korea.
  • Park KH; Division of Medical Oncology and Hematology, Department of Internal Medicine, Korea University Anam Hospital, Seoul, Korea.
Cancer Res Treat ; 55(1): 155-166, 2023 Jan.
Article em En | MEDLINE | ID: mdl-35681111
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Neoplasias da Mama Limite: Female / Humans Idioma: En Revista: Cancer Res Treat Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Neoplasias da Mama Limite: Female / Humans Idioma: En Revista: Cancer Res Treat Ano de publicação: 2023 Tipo de documento: Article